Market Insights
Microfluidics is the science of manipulating and controlling fluids inside micrometer-sized channels. The applications of microfluidics range from diagnostics to pharmaceutical research. Microfluidics is gaining high acceptance in the healthcare industry due to the rise in demand for point-of-care testing (POCT) and in vitro diagnostics.
The report titled “Global Microfluidics Market: Growth, Future Prospects, and Competitive Analysis, 2017–2025” offers strategic insights into the overall microfluidics market, along with the market size and estimates for the duration of 2017–2025. The research study covers an in-depth analysis of market segments based on application, material type, and different geographical regions.
In order to help strategic decision-makers, the report also includes sections on the competitive profiling of the leading players in the global microfluidics market, an attractive investment proposition, and the market positioning of key manufacturers. Geographically,
The global microfluidics market is studied for the following regional markets:
- North America
- Europe
- Germany
- France
- U.K.
- Italy
- Spain
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- South Korea
- South-east Asia
- Rest of Asia Pacific
- Latin America
- Brazil
- Mexico
- Rest of Latin America
- Middle East & Africa
- GCC Countries
- South Africa
- Rest of Middle East and Africa
The market size and forecast for these regional and country-level markets are presented in this study for the period 2015–2025. Market growth rates for the forecast period of 2015–2025 are also included in this report, considering 2016 as the base year.
Along with quantitative information, qualitative information sets and assessment tools are provided in this study for a better analysis of the overall market scenario and future prospects. Information such as market inclination insights and drivers, challenges, and opportunities assists the readers in understanding the ongoing trends in the global microfluidics market.
Tools such as key player market positioning and an appealing investment proposition provide readers with insights into the global microfluidics market’s competitive scenario. This report concludes with a company profiles section that highlights major information about the key players engaged in the global microfluidics market. In-depth competitive environment analysis and historical year (2015) market size data are also provided in the report.
Thus, the research study provides a holistic view of the global microfluidics market, offering market size and estimates for the period from 2015 to 2025, keeping in mind the above-mentioned factors.
Based on the type of material, the microfluidics market is segmented into:
- Polymer-Based Microfluidics
- Glass-Based Microfluidics
- Silicon-Based Microfluidics
- Others (metal, ceramic)
Microfluidics is the science of manipulating and controlling fluids inside micrometer-sized channels. The technology has evolved from Microelectromechanical Systems (MEMS) devices and can replicate all the functions of its counterparts in various healthcare applications, such as drug delivery, point-of-care (POC) testing, and clinical diagnostics. The global microfluidic market on the basis of material has been segmented into polymer-based microfluidics, glass-based microfluidics, silicon-based microfluidics, and others.
Polymer-based microfluidics held the largest market in 2016 due to higher reliability and rising applications in different diagnostic areas such as membrane protein measurement, collecting tumor cells, and others. Silicon-based material is expected to grow at the highest rate during the forecast period due to the increasing introduction of point-of-care (POC) testing. Moreover, it is easy to handle and more cost-effective.
Based on the type of application, the microfluidics market is segmented into:
Pharmaceutical Research
- Proteomic Analysis
- Genomic Analysis
- Cell-Based Assays
- Drug Delivery
In-Vitro Diagnostics
- Point-of-Care Testing
- Clinical Diagnostics
- Environmental Testing
- Industrial Testing
Microfluidics is the science of manipulating and controlling fluids inside micrometer-sized channels. The applications of microfluidics range from diagnostics to pharmaceutical research. Microfluidics is gaining high acceptance in the healthcare industry due to the rise in demand for point-of-care testing (POCT) and in vitro diagnostics. On the basis of application, the global microfluidics market is majorly segmented into pharmaceutical research and in-vitro diagnostics. The pharmaceutical research segment is further sub-segmented into proteomic analysis, genomic analysis, cell-based assays, and drug delivery.
The in-vitro diagnostic segment is further categorized into point-of-care testing, clinical diagnostics, environmental testing, and industrial testing. In-vitro diagnostics held the largest share in the microfluidics market due to rising demand for POCT due to the introduction of easy-step diagnostic techniques by companies such as Roche Diagnostics, Abbott, Cepheid, and others. POCT is further anticipated to grow at the fastest growth rate due to rising incidences of chronic and infectious diseases and emerging technologies in the field.
For the purpose of this study, the global microfluidic market is categorized into three segments:
- North America
- Europe
- Asia Pacific
- Latin America (LATAM)
- Middle East and Africa (MEA)
For the purpose of this study, the global microfluidic market is categorized into six regional markets: North America, Europe, Asia-Pacific, Latin America, the Middle East, and Africa. In the base year of 2016, North America dominated the global microfluidic market, followed by Europe and then Asia-Pacific.
The largest share of North America can be attributed to supportive insurance schemes for laboratory testing procedures, the incidence rate of various infectious diseases, sufficient reimbursements for medical devices, and the presence of well-structured distribution channels in the region. Moreover, the rising preference for point-of-care (POC) testing in the region is further driving the microfluidic market in North America.
In addition, the rising demand for home healthcare services and the increasing application of self-administered transdermal microneedles would further fuel the growth of the microfluidics market. Because of improving research infrastructure, heavy investments from key players in the region, and low labor costs, Asia Pacific is the fastest-growing region for microfluidics. In addition, the surge in the number of private hospitals and stand-alone clinics in the region would further guide the microfluidic market in the region.